Alvotech and Oaktree-backed SPAC to merge, will go public

Alvotech, an Icelandic global biopharmaceutical company, and Oaktree Acquisition Corp II, a blank check company, have agreed to merge.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this